PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of plosonePLoS OneView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
 
PLoS One. 2017; 12(8): e0184151.
Published online 2017 August 30. doi:  10.1371/journal.pone.0184151
PMCID: PMC5576682

Heterologous expression of anti-apoptotic human 14-3-3β/α enhances iron-mediated programmed cell death in yeast

Rawan Eid, Data curation, Methodology, Writing – original draft,1,2 David R. Zhou, Data curation, Writing – review & editing,3 Nagla T. T. Arab, Data curation,1,2 Eric Boucher, Data curation, Writing – review & editing,3 Paul G. Young, Methodology, Supervision,2 Craig A. Mandato, Methodology,3 and Michael T. Greenwood, Methodology, Supervision, Writing – original draft1,*
Hiroyasu Nakano, Editor

Abstract

The induction of Programmed Cell Death (PCD) requires the activation of complex responses involving the interplay of a variety of different cellular proteins, pathways, and processes. Uncovering the mechanisms regulating PCD requires an understanding of the different processes that both positively and negatively regulate cell death. Here we have examined the response of normal as well as PCD resistant yeast cells to different PCD inducing stresses. As expected cells expressing the pro-survival human 14-3-3β/α sequence show increased resistance to numerous stresses including copper and rapamycin. In contrast, other stresses including iron were more lethal in PCD resistant 14-3-3β/α expressing cells. The increased sensitivity to PCD was not iron and 14-3-3β/α specific since it was also observed with other stresses (hydroxyurea and zinc) and other pro-survival sequences (human TC-1 and H-ferritin). Although microscopical examination revealed little differences in morphology with iron or copper stresses, cells undergoing PCD in response to high levels of prolonged copper treatment were reduced in size. This supports the interaction some forms of PCD have with the mechanisms regulating cell growth. Analysis of iron-mediated effects in yeast mutant strains lacking key regulators suggests that a functional vacuole is required to mediate the synergistic effects of iron and 14-3-3β/α on yeast PCD. Finally, mild sub-lethal levels of copper were found to attenuate the observed inhibitory effects of iron. Taken together, we propose a model in which a subset of stresses like iron induces a complex process that requires the cross-talk of two different PCD inducing pathways.

Introduction

Cell death has been observed to occur in response to a variety of different conditions [1]. Classically, cellular death is separated into two basic forms, namely accidental and genetically encoded cellular suicide [2,3]. Accidental death, called necrosis, usually occurs in response to extreme stress and is not under the control of the cell. On the other hand, genetically encoded cell death occurs when a signaling and/or biochemical pathway is initiated resulting in the activation of cellular processes that lead to death via controlled cell destruction [2]. Historically, the term apoptosis was coined to describe all forms of genetically encoded cell death [4]. Early on, a separate form of programmed cell death that was associated with the accumulation of large vesicles, autophagosomes, was identified as being different from apoptosis and was called autophagy or type II PCD [5,6]. PCD has been and continues to be extensively investigated in part because it is disregulated in almost all human pathophysiologies [79]. One of the consequences of these extensive investigations is the identification of a large number and diversity of pathways that can serve to induce PCD. These multiple forms of PCD are associated with equally diversified cell death-inducing stimuli. Examples of such diversity include the induction of anoikis cell death in response to cellular detachment or the cell death called mitotic catastrophe that occurs when mitosis is interrupted [10,11]. More recently, a genetically encoded form of cell death resembling necrosis, called necroptosis, has been identified [12]. Stress-mediated PCD called intrinsic PCD, typically involves the activation of pro-apoptotic cascades mediated by the mitochondria [1315]. This process includes the activation of central pro-apoptotic regulators like Bax, damage to mitochondria, accumulation pro-apoptotic second messengers like ROS, ceramide, and iron as well as the activation of molecules such as proteases (i.e. caspases) and nucleases that actually disintegrate the cell [2,14,16]. Understanding the mechanisms as well as the processes that get activated in response to the different stresses has served to increase our understanding of PCD. For example, caspase 8 has been identified as being important for the activation of the extrinsic apoptotic response following the stimulation of death receptor by for instance Tumor Necrosis Factors (TNFα) [17].

A number of mechanisms exist that serve to negatively regulate PCD. Cellular process such as autophagy, misfolded protein degradation by the proteasome, or the activation of the ER stress response by misfolded proteins are well known pro-survival processes that limit stress mediated PCD [2,7,18,19]. Also very commonly observed is the up-regulation of anti-apoptotic or pro-survival genes [2,20]. Many of these sequences encode proteins that directly interfere with pro-apoptotic proteins, for example, Bcl-2 is a strong inhibitor of PCD by binding to and preventing the action of the pro-apoptotic mediator Bax [21]. Similarly, Inhibitors of Apoptosis (IAP) function by preventing the actions of caspases [22]. Pro-survival sequences that function to decrease the levels of intracellular pro-apoptotic second messengers are also commonly described [2,23]. These include Super Oxide Dismutase (SOD) that decrease the levels of free radicals and Sphingomyelin Synthase (SMS1) that decreases the levels of ceramide [2,24]. A number of proteins that have chaperone activity like Heat Shock Protein 70 (HSP70) serve to prevent stress-mediated cell death by assisting in the refolding of damaged or denatured proteins [25]. A surprisingly large number of functionally unknown proteins also have pro-survival functions [2]. The characterization of many pro-survival proteins, for example, the iron storage protein ferritin, has increased our knowledge of the importance of iron in PCD. Alternatively, the study of cells expressing anti-apoptotic proteins has served to uncover different PCD pathways as well as the functional cross-talk between that exists between different pathways [2,3]. Thus the inhibition of caspase 8 and apoptosis by overexpressing IAPs in cells stimulated with death receptor agonists leads to the activation of alternative necroptotic pathways [12,26]. Thus caspase 8 is thought to function as a possible inhibitor of necroptosis. Similar switching of cell death modalities from apoptotic to necroptosis in response to apoptotic inducing stress has been observed in cells lacking the pro-apoptotic regulator Bax [27].

The genetically tractable yeast S. cerevisiae has proven to be an exceptional model to study basic cellular processes including PCD [10,28]. Yeast cells will undergo PCD in response to the same stimuli and stresses that induce PCD in mammalian cells [14,29]. Yeast stress mediated PCD is centered on the mitochondria and involves the activation of key apoptotic regulators including a metacaspase and a Bh3 containing protein [13,14,30]. Finally, a number of key processes such as increases in ROS and externalization of phosphatidylserine (PS) also occur in yeast as in mammalian apoptosis. Thus apoptosis, necrosis/necroptosis, autophagic as well as other cell death modalities are being investigated in yeast [2,14,31,32]. A variety of original and novel observations regarding the basic processes of PCD are being uncovered using yeast. For example, the central role of acetyl-CoenzymeA in modulating lifespan was first identified in yeast [33]. We and others have used yeast as a screening platform to identify and characterize cDNA sequences that can prevent yeast cells from undergoing stress mediated PCD [34,35]. In this way, we identified human 14-3-3β/α as a potent inhibitor of multiple stresses in yeast [3537]. Yeast cells expressing 14-3-3β/α were found to be not only resistant to apoptosis but also to the cell death that occurs following prolonged autophagy inducing stimuli [36].

Here we examined the effect of different stresses on yeast cells expressing the pro-survival sequence human 14-3-3β/α [36]. As expected, these cells showed increased resistance to numerous PCD inducing stresses including copper and rapamycin. In contrast, 14-3-3β/α expressing cells showed a different response when challenged with other PCD inducing stresses including iron, hydroxyurea and zinc. In effect, 14-3-3β/α expressing cells were found to be hyperesponsive to the growth inhibitory and PCD inducing effects of iron. Analysis of mutants defective in genes involved in PCD responses revealed that the effect of iron required a functional vacuole. Taken together our results suggest that yeast activates at least two distinct pathways in response to some PCD stresses including iron.

Materials and methods

Yeast strains, plasmids, and growth

The Saccharomyces cerevisiae strain BY4742 (MATα his3Δ1 leu2Δ0 lys15Δ0 ura3Δ0) was used as the wild-type strain. All mutants YCA1Δ, YBH3Δ, ATG1Δ, VMA3Δ used in this study were isogenic to BY4742 and were obtained from ThermoScientific. Plasmids containing the cDNAs for 14-3-3β/α, TC-1, and FTH1 (human ferritin) expressed under the control of the galactose-inducible GAL1 promoter in pYES-DEST52 (URA3 selectable marker) were isolated in our previously described Bax screen [35]. The plasmids expressing the cDNAs for yeast YCA1 expressed under the control of the GAL1-galactose-inducible promoter were previously isolated and described [13,35,38]. The yeast media used in this study consists of yeast nitrogen base (YNB) and 2% glucose and the required amino acids (leucine, lysine, uracil and histidine). Yeast transformation was achieved by lithium acetate method and selected by omission of the appropriate nutrient. In order to induce the expression of sequences under the control of the GAL1 promoter, 2% galactose, and 1% raffinose were added instead of 2% glucose.

Spot and viability assays

To assess the ability of growth for different transformants in various kind conditions, spot assay was used [37]. Freshly glucose-grown saturated cultures of the different yeast transformants were diluted in fresh galactose media, incubated for 4–6 hours with shaking at 30°C, serially diluted ten fold with sterile water, and 5 μL of each dilution was spotted onto nutrient agar media followed by 3 to 4 days incubation at 30°C. The desired concentration of chemical stresses including copper sulfate (CuSO4) and iron chloride (FeCl3) were added directly to the media before pouring the plates as indicated in the figures. A concentration of 2.0 mM copper was used as the minimum concentration required to prevent the growth of wild type cells containing empty vector while 1.6 mM copper was used as the maximum concentration of copper that had minimal effect on growth of the control wild type cell [37]. A lower concentration of copper (0.5mM) was used to assess the growth of the VMA3Δ mutant. Iron was used at 6mM to assess its effect on the growth of wild type cells. In contrast, a higher concentration of iron (7mM) was used to assess the ability of sub-lethal copper to prevent the inhibitory effects of iron. A lower concentration of iron (2mM) was used to assess its effects on the growth of the VMA3Δ mutant. A minimum of three different spot assays with similar results were obtained. Viability was assessed by microscopic examination of cells stained with vital dye trypan blue, freshly inoculated galactose-growing cultures of the different transformants were challenged with copper sulfate (CuSO4) 1.4mM or iron chloride (FeCl3) 6mM and allowed to grow at 30°C for 18 hours. At least three different samples of 100 cells were scored for each experiment, and the experiments were repeated at least three independent times obtaining similar results. The data from the viability experiments are presented as the mean ± standard deviations of triplicate experiments repeated a minimum of three independent times. Statistical significance of the data was determined using a Student t-test. All described experiments were carried out a minimum of three independent times.

Iron assay

Cells were inoculated at low or moderate cell densities in fresh galactose media and the cultures were grown for 18 hours with or without the addition of 10X more iron (10μM) than standard YNB media (1μM). Cells were harvested and washed three times with cold 1mM EDTA, flash frozen and stored at -80°C. The cells were broken with 3% nitric acid (98°C, 18hours) and iron content was determined using a colorimetric assay using the iron chelator ferrozine [37,39]. All described experiments were carried out a minimum of three independent times.

Results

Human 14-3-3β/α suppresses copper and enhances iron-mediated cell death

Our lab has identified a number of pro-survival sequences by a direct screening of mammalian cDNA expression libraries in yeast cells undergoing PCD due to the expression of the pro-apoptotic Bax [35]. Although we confirmed the pro-survival function of many clones using stresses like copper, we did not fully explore the possibility that a specific sequence can selectively inhibit different PCD subroutines. One way to approach this is to determine if human 14-3-3β/α expression can prevent PCD in response to various stresses known to induce a different kind of cell death. Iron is an interesting compound for the study of PCD [4042]. It is both an essential element as well as being highly toxic at supraphysiological levels [4042]. In addition, excess intracellular iron is known to induce the production of highly toxic ROS species via the Fenton reaction [41]. Iron leads to DNA damage and this may contribute to the initiation of necrosis/necroptosis [43,44]. We were interested in determining the effect of iron on yeast cells expressing the previously characterized human pro-survival sequences 14-3-3β/α [36,38]. Using a spot assay, cells heterologously expressing 14-3-3β/α show the same growth as control cells containing empty vector when grown on agar media containing galactose alone with no additional stress (Fig 1A). Cells expressing 14-3-3β/α show more growth on media containing the lethal levels of copper when compared to control cells with vector alone (Fig 1A). This indicates, as previously described, that 14-3-3β/α is a pro-survival sequence capable of preventing PCD in response to stress [36]. When challenged with iron, the growth of the cells harboring 14-3-3β/α was noticeably inhibited compared to the control cells containing empty vector (Fig 1A). This suggests that heterologously expressed 14-3-3β/α increases the sensitivity of cells to the effects of iron. To determine if the observed effects with iron is a specific function of 14-3-3β/α, we examined TC-1 another previously characterized Bax suppressor that has been shown to attenuate the lethal effects of copper [38]. As with 14-3-3β/α, cells expressing TC-1 are more resistant to copper and more sensitive to iron (Fig 1A). This suggests that the observed iron effect is not specific to 14-3-3β/α.

Fig 1
The effects of iron, copper, and HU on cells expressing the anti-apoptotic sequence 14-3-3.

Because the spot assay measures net growth, we used microscopical examination of cells stained with the vital dye trypan blue to directly monitor the lethality of iron. The viability of cells in liquid culture was determined after 18h of incubation with or without iron or copper. For all strains, the viabilities remained above 98% after 18 hours of growth in the absence of additional stress (Fig 1B). In contrast, the viability of control cells had a decreased viability of 65% ± 5% when grown with iron and 27% ± 4% when grown with copper (Fig 1B). As expected, the cells expressing 14-3-3β/α showed a higher level of viability (78% ± 2%) when grown with copper as compared to control cells grown with copper (Fig 2B) [37,45,46]. In contrast, the viability of cells expressing 14-3-3β/α was decreased significantly when compared to control cells treated with iron (34% ± 15% vs. 65% ± 5%) (Fig 1B). This suggests that the expression of anti-apoptotic pro-survival sequences like 14-3-3β/α serves to enhance the lethality of iron.

Fig 2
The effect of iron and copper stress on cell morphology.

We have previously shown that 14-3-3β/α expressing cells are resistant not only to copper but also to a number of other stresses including rapamycin [36,45]. Iron may differ from these other stresses for a number of reasons such as its ability to damage DNA [47]. We thus examined the effect of zinc (ZnCl2) and hydroxyurea (HU) as a stress. HU is known for its ability to inhibit ribonucleotide reductase, reversibly arrest cells in S phase and induce DNA damage [48]. Zinc (Zn+) has been reported to interact with DNA, decrease mitochondrial membrane potential, and weaken lysosomal stability [49,50]. Using spot assays, cells expressing 14-3-3β/α showed similar growth as cells harbouring empty vector on nutrient agar media containing galactose alone (Fig 1C and 1D). When challenged with rapamycin (Rap), as expected, cells expressing 14-3-3β/α showed more growth than cells containing the empty vector (Fig 1C). In contrast, cells expressing 14-3-3β/α were noticeably more affected by zinc and HU than cells containing the empty vector (Fig 1C and 1D). This suggests that the anti-apoptotic sequence 14-3-3β/α is not specific only in enhancing the lethality of iron but also it does the same with zinc and HU. Taken together the results in this section suggests that overexpression of pro-survival sequences induce a cellular state that makes the cell resistant to the lethal effects of some stresses such as copper and rapamycin [36,38,45] while making the cell more sensitive to other stresses that include iron, zinc and HU.

Overexpressing or knocking out a gene and examining changes in phenotypes is a common genetic approach for exploring the function of individual genes in biological processes [51]. In spite of the many successes using these strategies, it remains that artifacts are known to occur with these approaches [52]. For example, global analysis of the entire repertoire of yeast genes revealed that many genes lead to a slow growth phenotype when overexpressed [52]. It seems likely that the slow growth phenotype observed with many sequences is the result of non-specific obstruction of cell processes and not due to a specific defect [51]. To address the possibility that the observed effects of 14-3-3β/α with iron may be non-specific, we generated yeast transformants that overexpress a different functional protein, namely the pro-apoptotic sequence YCA1 (also called MCA1) [13]. Using the spot assay, we thus examined how yeast cells overexpressing YCA1 differ in their response to copper and iron in comparison to control cells with empty vector. All four strains tested including empty vector control, as well as transformants harboring vectors for the expression of 14-3-3β/α, TC-1, and YCA1 show similar growth on control galactose agar media alone (Fig 1E). Differential effects on growth are observed when the strains are spotted on galactose inducing media containing copper or iron. On plates containing copper, the growth of the vector-containing control strain is greatly reduced, and this inhibition is, as expected, attenuated in cells expressing 14-3-3β/α or TC-1 (Fig 1E). In contrast, the growth of cells overexpressing YCA1 is more inhibited than the control strain (Fig 1E). The copper stress serves to activate the YCA1 protein leading to increased PCD [45]. As shown above (Fig 1A) with iron stress, the growth of the 14-3-3β/α and TC-1 expressing strain is reduced compared to the vector containing strain (Fig 1E). In contrast, the growth of YCA1 cells is noticeably less affected by the presence of iron compared to cells containing empty vector (Fig 1E). Thus overexpressed YCA1 is a functionally expressed protein that can enhance the effects of copper and does not alter a cell’s response to iron. Taken together, the effects of 14-3-3β/α and TC-1 on iron treated cells appear to be specifically linked to their pro-survival effects.

Morphology of iron and copper treated cells

In cultured mammalian cells, microscopical examination may serve to differentiate between different modes of cell death. For example, it is commonly observed that apoptotic cells remain intact during the early process of cell death while cells lose all structure and seem to explode early on during necrosis/necroptosis [3,53]. In contrast, the distinction between apoptosis and necrosis/necroptosis is not easily determined in yeast. It is known that apoptotic-like cell death can be induced in yeast by a variety of different stresses including acetic acid, copper, H2O2, and cycloheximide [3638,45,5456]. Necroptosis/necrosis cell death as well as the cell death that occurs in unstressed wild type cells in response to extracellular iron occurs in yeast but these processes have been much less studied [31,57]. A number of stresses, including iron, have been reported to favor the induction of necroptosis over other forms of PCD [31,43,47]. Thus we microscopically examined cells stained with the vital dye trypan blue in order to examine the morphology of both viable and inviable yeast cells treated with 1.4mM copper or 1mM iron (Fig 2A). It should be noted that 1mM represents a 1000-fold excess over the normal 1μM iron present in yeast YNB growth media [44]. As shown, two distinct cell types could be identified, namely clear live cells as well as dead cells that are blue (Fig 2A). In addition, we also observed what appeared to be some sort of debris in the medium associated with cells grown with iron (Fig 2A). This debris is likely some sort of iron precipitate, since it can be observed to increase in a dose dependant manner when iron alone is added to the YNBD growth media (Fig 2B). The tendency of iron to precipitate with time, altered pH or in mixed solutions is one of the major and common problems associated with matintaining iron at sufficiently high concentrations to induce cell death in normal unstressed cells [42,44].

It remained that we were still interested in determining if we could observe alterations in cell morphology with different stresses. An alternative way to induce necrosis/necroptosis is to increase the concentration or duration of a normally apoptotic inducing stress [54]. Thus we examined cells that were treated for 6 or 18hours with 1.4mM copper or 18hours with 50mM copper. Although there was a decrease in viability with the first two conditions (respectively 80%, 30%), there was no noticeable change in cellular morphology. Similarly, there were no observable necrotic-like morphology in cells treated with 50mM copper even though a more pronounced decrease in viability was observed (20%) (Fig 2C). Nevertheless, we do observe a decrease in cell size in these cells (Fig 2C). The decrease more than likely reflects that cell size is reduced in slower growing cells and that stressed cells reduce their growth rate prior to initiating PCD [58,59]. We also examined the morphology of yeast cells that were incubated at 80°C for 20 min. Following this treatment, all of the cells appeared blue indicating that they were all dead. In spite of this, all the cells appear to have maintained their intact cellular morphology (Fig 2D). Taken together the results here show that either iron can not induce a cell death that resembles necrosis or that necrotic yeast cells do not differ in their morphology compared to apoptotic cells.

Analysis of 14-3-3β/α and iron in mutants defective in apoptosis, autophagy, and vacuolar function

Identification of specific proteins involved in mediating the PCD inducing effects of different stresses can serve to characterize different PCD pathways [2,3]. For example, using genetic approaches, it has been found that the yeast metacaspase YCA1p is involved in mediating the effects of acetic acid but not copper [13,54]. Thus here we used mutants devoid of key genes involved in regulating PCD including YCA1, YBH3 (a BH3 containing Bax-like protein) and ATG1 (autophagy-defective) to examine their possible roles in mediating the effects of iron with 14-3-3β/α. The mutants were transformed with empty vector or 14-3-3β/α expressing plasmid and their growth in the presence of copper and iron were determined using the spot assay (Fig 3A). All the mutants showed growth inhibition by copper and iron. As shown previously (Fig 1A) [45], the expression of 14-3-3β/α was able to increase copper resistance as determined by increased growth for all three mutants examined (Fig 3A). As observed in wild-type cells, the expression of 14-3-3β/α served to enhance the inhibitory effect of iron in the three mutants examined. These results indicate YCA1, YBH3, and ATG1 are not likely involved in mediating the effects of 14-3-3β/α on iron.

Fig 3
The effects of copper and iron on yeast mutant cells.

In yeast, the vacuole (lysosome in mammals) is critical for iron metabolism [60]. Thus many mutants defective in vacuolar function are hypersensitive to iron [37,60,61]. In addition, the vacuole/lysosome has been linked to the induction of necrosis/necroptosis [62]. Mutants defective in the vacuolar proton pump due to the loss of one of the many different genes that encode for the Vacuolar Membrane ATPase (VMA) show reduced vacuolar function, are more resistant to necroptosis and are hypersensitive to iron [61,63]. The mutant VMA3Δ as well as the wild-type strain were transformed with empty vector or the 14-3-3β/α expressing plasmid and their ability to grow with copper and iron evaluated using the spot assay (Fig 3B). The VMA3Δ mutant with and without 14-3-3β/α were able to grow like the wild strain on galactose-inducible media (Fig 3B). In contrast, the VMA3Δ mutant showed enhanced sensitivity to copper and iron when compared to wild-type cells (Fig 3B). Thus VMA3Δ cells with empty vector showed significantly reduced growth in the presence of 0.5mM copper or 2mM iron. In contrast, these concentrations of iron or copper did not affect the growth of wild-type cells (Fig 3B). Thus we evaluated the effects of copper and iron respectively at 0.5mM and 2mM. At these concentrations both copper and iron had no effect on the growth of wild-type cells (Fig 3B). In spite of the increased sensitivity, the expression of 14-3-3β/α served to promote the growth of VMA3Δ cells treated with copper or iron (Fig 3B). This is in contrast to the effects of iron, in wild-type cells where the expression of 14-3-3β/α enhances the inhibitory effects of iron (Fig 3B and also see Fig 1). In the mutants, the expression of 14-3-3β/α now serves to attenuate the inhibitory effects of iron (Fig 3B). This indicates that there is a difference in response to iron in the VMA3Δ mutant. These data not only confirm that a functional vacuole is required for resistance to multiple stresses including iron [61], but that it is also crucial for mediating the normal and specific PCD responses to high iron stress [37,60].

Copper conditioning prevents iron inhibition

It is well known that there is significant cross talk between different PCD stress responsive pathways [2,18,64]. To further examine possible differences between the iron and copper responses we examined if there is cross- talk between the copper and iron-responsive pathways. To do this, we made use of the fact that sub-lethal levels of stresses are known to induce a protective state often called pre-conditioning or hormesis that increases resistance to stronger PCD inducing stresses [7,65]. The protective sub-lethal stress can be added not only prior to the lethal stress but also can be added after or at the same time of the lethal stress [66]. Thus we grew yeast transformants with sublethal copper in the presence and absence of lethal levels of iron. Freshly saturated cultures of control, as well as 14-3-3β/α expressing yeast transformants, were serially diluted and spotted onto nutrient agar media containing 1.6mM CuSO4, 7mM FeCl3 or both 1.6mM CuSO4 and 7mM FeCl3. There is no difference in the growth of cells grown on galactose media with or without the presence of 1.6mM CuSO4 in the media (Fig 4). In the presence of 7mM FeCl3, there was a significant decrease in the growth of cells containing the empty vector which was enhanced in cells expressing 14-3-3β/α (Fig 4). In contrast, the growth of both transformants in the presence of iron was enhanced by sub-lethal copper. This suggests that conditioning with sub-lethal copper reduces the lethal effects of iron and further support fundamental differences existing in processes mediated by copper and iron.

Fig 4
Sub-lethal copper conditioning inhibits iron-mediated 14-3-3 lethality.

Human ferritin protects against copper but not iron stress

Cell death mediated by extracellular stresses is a complex process that is in large part dictated by the nature of the stress used [7,64,67]. Many stress including compounds such as hydrogen peroxide are freely diffusible and cause stress by entering the cell, reacting with cellular constituents and producing free radicals. Others, such as iron and copper are not so simple. Although both these ions are essential micronutrients and are critical for cell growth they are also very toxic at elevated levels [44]. As a consequence, an increase in the intracellular levels of most micronutrients is limited by a large number of regulatory processes even when the extracellular concentration of a micronutrient is high [2,68]. We have documented this process here for iron. Normal minimal YNB growth media used for yeast contains ca. 1μM iron. We grew yeast cells in the presence of a 10-fold excess iron, a concentration where all the iron remains soluble [44]. As we have previously shown for wild type cells, the observed increase in total intracellular iron was limited to 60%, indicating that increases in intracellular iron are effectively limited (Fig 5A) [37,69]. For iron, the situation is even more complicated by the fact that many PCD inducing stresses, including extracellular iron, lead to increases in levels of free bioactive iron [44]. Thus, the fact that intracellular iron chelators can prevent stress mediated PCD strongly supports the notion that iron is a stress inducible intracellular pro-apoptotic second messenger much like ROS and ceramide [57]. Overexpression of mammalian ferritin is reported to increase total iron content in mammalian and in yeast cells and protect the cells from stress including excess iron [37,70,71]. We and others have previously shown that human ferritin can prevent iron mediated cell death but only in iron supersensitive mutants [37,71,72]. The ability to attenuate the effects of iron in wild type yeast has actually never been examined for ferritin. Here we show as expected from our previous studies, using spot assays, that wild type yeast cells that are expressing human ferritin are more resistant to the effects of copper (Fig 5B). In contrast the expression of ferritin renders wild type more sensitive to the negative effects of iron (Fig 5B). This is similar to what we observe with 14-3-3 which suggests that ferritin in yeast retains its pro-survival function. The measurement of the total iron content of ferritin expressing yeast cells grown with a 10-fold excess of iron did not differ from what we observe in control cells (Fig 5A). This suggests that ferritin cannot be used to manipulate total iron content in yeast. As an alternate method to quench and sequester excess intracellular iron and to decrease stress mediated PCD is to use cell permeable iron chelators [73]. Unfortunately the use of an iron chelator to study the role of intracellular iron in mediating the effect of extracellular iron are difficult and we were unable to show an effect of iron chelators with hydroxyurea (not shown).

Fig 5
Ferritin enhances iron toxicity and doesn’t show enhanced iron storage in yeast.

Discussion

In this study, we examined the ability of anti-apoptosis induced by the expression of human 14-3-3β/α to prevent cell death in response to different stresses. We hypothesized that different stresses would induce different forms of PCD that could be differentially inhibited by 14-3-3β/α. We had previously shown that 14-3-3β/α could inhibit PCD from multiple stresses including copper and rapamycin as well as block different processes including apoptosis and autophagic cell death as induced by prolonged leucine starvation [14,3638,45]. Thus it was surprising to find that wild type cells expressing 14-3-3β/α showed an increased sensitivity to iron (Fig 1A and 1B). The ability to prevent iron-mediated cell death by inducing anti-apoptosis has surprisingly been little studied [74]. In fact, most of the studies that examine iron mediated programmed cell death induced by iron are themselves not studying iron alone as an inducer of apoptosis or other forms of PCD. This is in large part due to the rather low solubility of iron and the difficulty in maintaining concentrations of iron in the growth media that are sufficiently high to induce PCD (Fig 2B) [44]. To circumvent these problems, most studies have used sub-lethal iron concentrations in combination with other sub-lethal stresses [44,74,75]. For example, serum free medium is commonly used, but not commonly acknowledged, as a sub-lethal secondary stress that is absolutely required to induce iron mediated apoptosis [44]. With yeast, we and others have largely used yeast mutants that are supersensitive to iron in order to induce PCD that is characterized as being iron mediated [37,44]. Thus we were able to show that the expression of the pro-survival human ferritin could prevent iron mediated PCD in the iron sensitive VMA3Δ yeast strain but not in the wild type cell. Our results show that there is clearly a difference in studying iron mediated cell death in the presence or absence of any other secondary sub-lethal stress.

Our main finding is that blocking PCD by expressing an anti-apoptotic sequence (14-3-3β/α) makes a cell super sensitive to the growth inhibitory as well as the cell death-inducing effects of iron (Fig 1). These results are reminiscent of the studies that have reported on the effect of blocking of apoptosis with caspase 8 inhibitors, in cells induced to undergo apoptosis by death receptor agonists [12,26]. Indeed, instead of activating the extrinsic apoptotic pathway, these cells were found to induce an alternate cell death pathway that resembles necroptosis [26]. A model in which death receptor simultaneoulsy activates both apoptosis and necroptosis appears to explain the observation [26]. In this model, caspase 8 would serve to simultaneously activate the apoptotic pathway and inhibit the necroptotic pathway. Blocking caspase 8 would thus prevent apoptosis and activate necroptosis. This type of cross-talk would then allow a cell more control over the process of PCD depending on the cellular context. Inspired by the work on caspase 8 we have developed a similar model that is based on the existence of two different but cross-talking PCD pathways in yeast (Fig 6). One of the pathways is activated by copper. This pathway leads to a programmed cell death that can be inhibited by the expression of 14-3-3β/α [37,38,76]. Iron differs since it activates the copper pathway all the while simultaneously activating a second pathway. The activated copper pathway would negatively regulate the iron pathway. This would explain why blocking the copper pathway by expressing 14-3-3β/α would enhance the lethal effects of iron. In cells where the iron specific pathway is blocked due to loss of vacuolar function (VAM3Δ), iron would activate only the copper pathway. This would explain why iron mediated PCD is blocked by 14-3-3β/α in the VAM3Δ cells. The vacuole (lysosome) has been shown to be involved in mediated the process of cell death [2,44,62,63]. During necrosis and necroptosis, the lysosome is thought to break open resulting in the spillage of catalytically active destructive proteins including proteases and RNAses as well as other destructive materials such as redox active iron that serve to help in the destruction of the cell. Thus cells with reduced vacuolar function are thought to be more resistant to the induction of necroptosis. Our model suggests that a functional vacuole is actively involved in mediating the cell death inducing responses to some stresses such as iron.

Fig 6
A model depicting the cross-talk between copper and iron mediated PCD in yeast.

Finally, we exploited the fact that in all cells including yeast, exposure to sub-lethal stress can lead to both an increase in the resistance to a higher concentration of the same stress as well as an increase resistance to heterologous stresses [7779]. We showed that wild type cells growing on media containing sub-lethal copper are more resistant to high levels of iron (Fig 4). These results further support the model by demonstrating that there is functional cross-talk between iron and copper pathways in yeast (Fig 6). We are currently testing this model by using chemical inhibitors of the vacuole as well as screening for genes that would prevent iron mediated cell death in cells expressing 14-3-3β/α.

In conclusion, our results suggests that there is a complex interplay between the processes that activate and prevent programmed cell death in response to different stresses in yeast.

Acknowledgments

We thank the Greenwood and Mandato labs for their helpful discussions.

Funding Statement

This work was supported by the Natural Sciences and Engineering Research Council of Canada 217502-2009 RGPIN. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Data Availability

Data Availability

All relevant data are included within the paper.

References

1. Fulda S, Gorman AM, Hori O, Samali A. Cellular stress responses: cell survival and cell death. Int J Cell Biol. 2010;2010: 214074 doi: 10.1155/2010/214074 [PMC free article] [PubMed]
2. Portt L, Norman G, Clapp C, Greenwood M, Greenwood MT. Anti-apoptosis and cell survival: a review. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research. 2011;1813: 238–259. [PubMed]
3. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007;35: 495–516. doi: 10.1080/01926230701320337 [PMC free article] [PubMed]
4. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26: 239–257. [PMC free article] [PubMed]
5. Denton D, Nicolson S, Kumar S. Cell death by autophagy: facts and apparent artefacts. Cell Death & Differentiation. 2012;19: 87–95. [PMC free article] [PubMed]
6. Yang Z, Klionsky DJ. Eaten alive: a history of macroautophagy. Nat Cell Biol. 2010;12: 814–822. doi: 10.1038/ncb0910-814 [PMC free article] [PubMed]
7. Clapp C, Portt L, Khoury C, Sheibani S, Eid R, Greenwood M, et al. Untangling the roles of anti-apoptosis in regulating programmed cell death using humanized yeast cells. Frontiers in oncology. 2012;2: 59 doi: 10.3389/fonc.2012.00059 [PMC free article] [PubMed]
8. Tsujimoto Y, Shimizu S. Another way to die: autophagic programmed cell death. Cell Death & Differentiation. 2005;12: 1528–1534. [PubMed]
9. Wyllie AH. “Where, O death, is thy sting?” A brief review of apoptosis biology. Mol Neurobiol. 2010;42: 4–9. doi: 10.1007/s12035-010-8125-5 [PMC free article] [PubMed]
10. Botstein D, Fink GR. Yeast: an experimental organism for 21st Century biology. Genetics. 2011;189: 695–704. doi: 10.1534/genetics.111.130765 [PubMed]
11. Vakifahmetoglu H, Olsson M, Zhivotovsky B. Death through a tragedy: mitotic catastrophe. Cell Death & Differentiation. 2008;15: 1153–1162. [PubMed]
12. Vasilikos L, Spilgies LM, Knop J, Wong WW. Regulating the balance between necroptosis, apoptosis and inflammation by inhibitors of apoptosis proteins. Immunol Cell Biol. 2017. [PubMed]
13. Madeo F, Herker E, Maldener C, Wissing S, Lächelt S, Herlan M, et al. A caspase-related protease regulates apoptosis in yeast. Mol Cell. 2002;9: 911–917. [PubMed]
14. Carmona-Gutierrez D, Eisenberg T, Büttner S, Meisinger C, Kroemer G, Madeo F. Apoptosis in yeast: triggers, pathways, subroutines. Cell Death & Differentiation. 2010;17: 763–773. [PubMed]
15. Pereira C, Silva R, Saraiva L, Johansson B, Sousa M, Côrte-Real M. Mitochondria-dependent apoptosis in yeast. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research. 2008;1783: 1286–1302. [PubMed]
16. Manon S, Chaudhuri B, Guérin M. Release of cytochrome c and decrease of cytochrome c oxidase in Bax‐expressing yeast cells, and prevention of these effects by coexpression of Bcl‐xL. FEBS Lett. 1997;415: 29–32. [PubMed]
17. Priault M, Camougrand N, Kinnally KW, Vallette FM, Manon S. Yeast as a tool to study Bax/mitochondrial interactions in cell death. FEMS Yeast Res. 2003;4: 15–27. [PubMed]
18. Moreau K, Luo S, Rubinsztein DC. Cytoprotective roles for autophagy. Curr Opin Cell Biol. 2010;22: 206–211. doi: 10.1016/j.ceb.2009.12.002 [PMC free article] [PubMed]
19. Schönthal AH. Endoplasmic reticulum stress and autophagy as targets for cancer therapy. Cancer Lett. 2009;275: 163–169. doi: 10.1016/j.canlet.2008.07.005 [PubMed]
20. Saxena M, Kryworuchko M, Kumar A. Anti-apoptotic genes in the survival of monocytic cells during infection. Curr Genomics. 2009;10: 306–317. doi: 10.2174/138920209788920967 [PMC free article] [PubMed]
21. Brunelle JK, Letai A. Control of mitochondrial apoptosis by the Bcl-2 family. J Cell Sci. 2009;122: 437–441. doi: 10.1242/jcs.031682 [PubMed]
22. Wright ME, Han DK, Hockenbery DM. Caspase‐3 and inhibitor of apoptosis protein (s) interactions in Saccharomyces cerevisiae and mammalian cells. FEBS Lett. 2000;481: 13–18. [PubMed]
23. Williams D, Norman G, Khoury C, Metcalfe N, Briard J, Laporte A, et al. Evidence for a second messenger function of dUTP during Bax mediated apoptosis of yeast and mammalian cells. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research. 2011;1813: 315–321. [PubMed]
24. Thiruchelvam M, Prokopenko O, Cory-Slechta DA, Buckley B, Mirochnitchenko O. Overexpression of superoxide dismutase or glutathione peroxidase protects against the paraquat + maneb-induced Parkinson disease phenotype. J Biol Chem. 2005;280: 22530–22539. doi: 10.1074/jbc.M500417200 [PubMed]
25. Mayer M, Bukau B. Hsp70 chaperones: cellular functions and molecular mechanism. Cellular and molecular life sciences. 2005;62: 670 doi: 10.1007/s00018-004-4464-6 [PMC free article] [PubMed]
26. Vanlangenakker N, Berghe TV, Vandenabeele P. Many stimuli pull the necrotic trigger, an overview. Cell Death & Differentiation. 2012;19: 75–86. [PMC free article] [PubMed]
27. Shimizu S, Kanaseki T, Mizushima N, Mizuta T, Arakawa-Kobayashi S, Thompson CB, et al. Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat Cell Biol. 2004;6: 1221–1228. doi: 10.1038/ncb1192 [PubMed]
28. Hartwell LH. Nobel lecture: Yeast and cancer. Biosci Rep. 2002;22: 373–394. [PubMed]
29. Matsuyama S, Nouraini S, Reed JC. Yeast as a tool for apoptosis research. Curr Opin Microbiol. 1999;2: 618–623. [PubMed]
30. Buttner S, Ruli D, Vogtle FN, Galluzzi L, Moitzi B, Eisenberg T, et al. A yeast BH3-only protein mediates the mitochondrial pathway of apoptosis. EMBO J. 2011;30: 2779–2792. doi: 10.1038/emboj.2011.197 [PubMed]
31. Eisenberg T, Carmona-Gutierrez D, Büttner S, Tavernarakis N, Madeo F. Necrosis in yeast. Apoptosis. 2010;15: 257–268. doi: 10.1007/s10495-009-0453-4 [PubMed]
32. Eisenberg T, Knauer H, Schauer A, Büttner S, Ruckenstuhl C, Carmona-Gutierrez D, et al. Induction of autophagy by spermidine promotes longevity. Nat Cell Biol. 2009;11: 1305–1314. doi: 10.1038/ncb1975 [PubMed]
33. Pietrocola F, Galluzzi L, Bravo-San Pedro JM, Madeo F, Kroemer G. Acetyl coenzyme A: a central metabolite and second messenger. Cell metabolism. 2015;21: 805–821. doi: 10.1016/j.cmet.2015.05.014 [PubMed]
34. D Silva R, Manon S, Goncalves J, Saraiva L, Côrte-Real M. The importance of humanized yeast to better understand the role of bcl-2 family in apoptosis: finding of novel therapeutic opportunities. Curr Pharm Des. 2011;17: 246–255. [PubMed]
35. Yang Z, Khoury C, Jean-Baptiste G, Greenwood MT. Identification of mouse sphingomyelin synthase 1 as a suppressor of Bax-mediated cell death in yeast. FEMS Yeast Res. 2006;6: 751–762. doi: 10.1111/j.1567-1364.2006.00052.x [PubMed]
36. Clapp C, Portt L, Khoury C, Sheibani S, Norman G, Ebner P, et al. 14-3-3 protects against stress-induced apoptosis. Cell death & disease. 2012;3: e348. [PMC free article] [PubMed]
37. Eid R, Boucher E, Gharib N, Khoury C, Arab NT, Murray A, et al. Identification of human ferritin, heavy polypeptide 1 (FTH1) and yeast RGI1 (YER067W) as pro-survival sequences that counteract the effects of Bax and copper in Saccharomyces cerevisiae. Exp Cell Res. 2016;342: 52–61. doi: 10.1016/j.yexcr.2016.02.010 [PubMed]
38. Jones NK, Arab NT, Eid R, Gharib N, Sheibani S, Vali H, et al. Human Thyroid Cancer-1 (TC-1) is a vertebrate specific oncogenic protein that protects against copper and pro-apoptotic genes in yeast. Microb Cell. 2015;2: 247–255. doi: 10.15698/mic2015.07.213 [PMC free article] [PubMed]
39. Tamarit Sumalla J, Irazusta VP, Moreno Cermeño AJ, Ros Salvador J. Colorimetric assay for the quantitation of iron in yeast. Analytical Biochemistry, 2006, vol.351, núm.1, p.149–151. 2006. doi: 10.1016/j.ab.2005.12.001 [PubMed]
40. Zhang C. Essential functions of iron-requiring proteins in DNA replication, repair and cell cycle control. Protein & cell. 2014;5: 750–760. [PMC free article] [PubMed]
41. Winterbourn CC. Toxicity of iron and hydrogen peroxide: the Fenton reaction. Toxicol Lett. 1995;82: 969–974. [PubMed]
42. Bou-Abdallah F. The iron redox and hydrolysis chemistry of the ferritins. Biochimica et Biophysica Acta (BBA)-General Subjects. 2010;1800: 719–731. [PubMed]
43. Munoz JP, Chiong M, García L, Troncoso R, Toro B, Pedrozo Z, et al. Iron induces protection and necrosis in cultured cardiomyocytes: Role of reactive oxygen species and nitric oxide. Free Radical Biology and Medicine. 2010;48: 526–534. doi: 10.1016/j.freeradbiomed.2009.11.017 [PubMed]
44. Eid R, Arab NT, Greenwood MT. Iron mediated toxicity and Programmed Cell Death: A review and a re-examination of existing paradigms. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research. 2016. [PubMed]
45. Eid R, Sheibani S, Gharib N, Lapointe JF, Horowitz A, Vali H, et al. Human ribosomal protein L9 is a Bax suppressor that promotes cell survival in yeast. FEMS Yeast Res. 2014;14: 495–507. doi: 10.1111/1567-1364.12121 [PubMed]
46. Spincemaille P, Chandhok G, Newcomb B, Verbeek J, Vriens K, Zibert A, et al. The plant decapeptide OSIP108 prevents copper-induced apoptosis in yeast and human cells. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research. 2014;1843: 1207–1215. [PMC free article] [PubMed]
47. Meneghini R. Iron homeostasis, oxidative stress, and DNA damage. Free Radical Biology and Medicine. 1997;23: 783–792. [PubMed]
48. Koc A, Wheeler LJ, Mathews CK, Merrill GF. Hydroxyurea arrests DNA replication by a mechanism that preserves basal dNTP pools. J Biol Chem. 2004;279: 223–230. doi: 10.1074/jbc.M303952200 [PubMed]
49. Rudolf E, Červinka M. Zinc pyrithione induces cellular stress signaling and apoptosis in Hep-2 cervical tumor cells: the role of mitochondria and lysosomes. Biometals. 2010;23: 339–354. doi: 10.1007/s10534-010-9302-8 [PubMed]
50. Sensi SL, Ton-That D, Sullivan PG, Jonas EA, Gee KR, Kaczmarek LK, et al. Modulation of mitochondrial function by endogenous Zn2+ pools. Proc Natl Acad Sci U S A. 2003;100: 6157–6162. doi: 10.1073/pnas.1031598100 [PubMed]
51. Prelich G. Gene overexpression: uses, mechanisms, and interpretation. Genetics. 2012;190: 841–854. doi: 10.1534/genetics.111.136911 [PubMed]
52. Stevenson LF, Kennedy BK, Harlow E. A large-scale overexpression screen in Saccharomyces cerevisiae identifies previously uncharacterized cell cycle genes. Proc Natl Acad Sci U S A. 2001;98: 3946–3951. doi: 10.1073/pnas.051013498 [PubMed]
53. Majno G, Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol. 1995;146: 3–15. [PubMed]
54. Liang Q, Zhou B. Copper and manganese induce yeast apoptosis via different pathways. Mol Biol Cell. 2007;18: 4741–4749. doi: 10.1091/mbc.E07-05-0431 [PMC free article] [PubMed]
55. Madeo F, Frohlich E, Ligr M, Grey M, Sigrist SJ, Wolf DH, et al. Oxygen stress: a regulator of apoptosis in yeast. J Cell Biol. 1999;145: 757–767. [PMC free article] [PubMed]
56. Ludovico P, Sousa MJ, Silva MT, Leão C, Côrte-Real M. Saccharomyces cerevisiae commits to a programmed cell death process in response to acetic acid. Microbiology. 2001;147: 2409–2415. doi: 10.1099/00221287-147-9-2409 [PubMed]
57. Dixon SJ, Stockwell BR. The role of iron and reactive oxygen species in cell death. Nature chemical biology. 2014;10: 9–17. doi: 10.1038/nchembio.1416 [PubMed]
58. Aldea M, Jenkins K, Csikász-Nagy A. Growth rate as a direct regulator of the Start network to set cell size. Frontiers in Cell and Developmental Biology. 2017;5 doi: 10.3389/fcell.2017.00005 [PMC free article] [PubMed]
59. Tyson CB, Lord PG, Wheals AE. Dependency of size of Saccharomyces cerevisiae cells on growth rate. J Bacteriol. 1979;138: 92–98. [PMC free article] [PubMed]
60. Li L, Chen OS, McVey Ward D, Kaplan J. CCC1 is a transporter that mediates vacuolar iron storage in yeast. J Biol Chem. 2001;276: 29515–29519. doi: 10.1074/jbc.M103944200 [PubMed]
61. Szczypka MS, Zhu Z, Silar P, Thiele DJ. Saccharomyces cerevisiae mutants altered in vacuole function are defective in copper detoxification and iron-responsive gene transcription. 1997. [PubMed]
62. Turk B, Turk V. Lysosomes as "suicide bags" in cell death: myth or reality? J Biol Chem. 2009;284: 21783–21787. doi: 10.1074/jbc.R109.023820 [PMC free article] [PubMed]
63. Kim H, Kim A, Cunningham KW. Vacuolar H+-ATPase (V-ATPase) promotes vacuolar membrane permeabilization and nonapoptotic death in stressed yeast. J Biol Chem. 2012;287: 19029–19039. doi: 10.1074/jbc.M112.363390 [PMC free article] [PubMed]
64. Ho Y, Gasch AP. Exploiting the yeast stress-activated signaling network to inform on stress biology and disease signaling. Curr Genet. 2015;61: 503–511. doi: 10.1007/s00294-015-0491-0 [PMC free article] [PubMed]
65. Berry DB, Gasch AP. Stress-activated genomic expression changes serve a preparative role for impending stress in yeast. Mol Biol Cell. 2008;19: 4580–4587. doi: 10.1091/mbc.E07-07-0680 [PMC free article] [PubMed]
66. Wang Y, Reis C, Applegate R, Stier G, Martin R, Zhang JH. Ischemic conditioning-induced endogenous brain protection: applications pre-, per-or post-stroke. Exp Neurol. 2015;272: 26–40. doi: 10.1016/j.expneurol.2015.04.009 [PMC free article] [PubMed]
67. Orrenius S, Nicotera P, Zhivotovsky B. Cell death mechanisms and their implications in toxicology. Toxicol Sci. 2011;119: 3–19. doi: 10.1093/toxsci/kfq268 [PubMed]
68. Bleackley MR, MacGillivray RT. Transition metal homeostasis: from yeast to human disease. Biometals. 2011;24: 785–809. doi: 10.1007/s10534-011-9451-4 [PubMed]
69. Castells-Roca L, Pijuan J, Ferrezuelo F, Bellí G, Herrero E. Cth2 protein mediates early adaptation of yeast cells to oxidative stress conditions. PloS one. 2016;11: e0148204 doi: 10.1371/journal.pone.0148204 [PMC free article] [PubMed]
70. Goralska M, Holley BL, McGahan MC. Overexpression of H-and L-ferritin subunits in lens epithelial cells: Fe metabolism and cellular response to UVB irradiation. Invest Ophthalmol Vis Sci. 2001;42: 1721–1727. [PubMed]
71. Seo H, Chung Y, Kim S, Park C, Kim K. Enhanced expression and functional characterization of the human ferritin H-and L-chain genes in Saccharomyces cerevisiae. Appl Microbiol Biotechnol. 2003;63: 57–63. doi: 10.1007/s00253-003-1350-3 [PubMed]
72. Nishida K, Silver PA. Induction of biogenic magnetization and redox control by a component of the target of rapamycin complex 1 signaling pathway. PLoS biology. 2012;10: e1001269 doi: 10.1371/journal.pbio.1001269 [PMC free article] [PubMed]
73. Almeida T, Marques M, Mojzita D, Amorim MA, Silva RD, Almeida B, et al. Isc1p plays a key role in hydrogen peroxide resistance and chronological lifespan through modulation of iron levels and apoptosis. Mol Biol Cell. 2008;19: 865–876. doi: 10.1091/mbc.E07-06-0604 [PMC free article] [PubMed]
74. Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149: 1060–1072. doi: 10.1016/j.cell.2012.03.042 [PMC free article] [PubMed]
75. Jacob AK, Hotchkiss RS, DeMeester SL, Hiramatsu M, Karl IE, Swanson PE, et al. Endothelial cell apoptosis is accelerated by inorganic iron and heat via an oxygen radical dependent mechanism. Surgery. 1997;122: 243–254. [PubMed]
76. Horowitz A, Lapointe JF, Eid R, Sheibani S, Gharib N, Jones NK, et al. The human septin7 and the yeast CDC10 septin prevent Bax and copper mediated cell death in yeast. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research. 2013;1833: 3186–3194. [PubMed]
77. Święciło A. Cross-stress resistance in Saccharomyces cerevisiae yeast—new insight into an old phenomenon. Cell Stress and Chaperones. 2016;21: 187–200. doi: 10.1007/s12192-016-0667-7 [PMC free article] [PubMed]
78. Balakumar P, Rohilla A, Singh M. Pre-conditioning and postconditioning to limit ischemia–reperfusion-induced myocardial injury: What could be the next footstep? Pharmacological Research. 2008;57: 403–412. doi: 10.1016/j.phrs.2008.05.006 [PubMed]
79. Chang S, Jiang X, Zhao C, Lee C, Ferriero DM. Exogenous low dose hydrogen peroxide increases hypoxia-inducible factor-1alpha protein expression and induces preconditioning protection against ischemia in primary cortical neurons. Neurosci Lett. 2008;441: 134–138. doi: 10.1016/j.neulet.2008.06.005 [PMC free article] [PubMed]

Articles from PLoS ONE are provided here courtesy of Public Library of Science